Table 1: Summary of vaccination recommendations for HIV-infected adults
Vaccine |
Recommendation |
Diphtheria, tetanus, pertussis |
According to routine recommendations |
Haemophilus influenza type B |
According to routine recommendations |
Hepatitis A virus |
2 doses (0, 6 months) for at risk groups with CD4+ T cells >350/mL 3 doses (0, 1, 6 months) for at risk groups if CD4+ T cells <350/mL |
Hepatitis B virus |
3 doses (0, 1, and 6 months) 40mg if nonimmune Check HBsAb 4-8 weeks after last dose, if <10IU, 1x 40mg dose |
Human papilloma virus |
Females <45 years and males <26 years 3 doses (0, 1, 6 months) |
Influenza virus |
Annual |
Measles, mumps, rubella viruses |
1 or 2 doses if CD4+ T cells >200/mL and non-immune Not recommended if CD4+ T cells <200/mL |
Meningococcal ACWY |
2 doses |
Meningococcal B |
2 doses (no clinical data but recommended) |
Pneumococcal conjugate 13 |
1 dose all |
Pneumococcal polysaccharide 23 |
1 dose at least 12 months after PCV13 Repeat dose 5 years later (2 lifetime doses) |
Varicella virus |
2 doses if CD4+ T cells >200/mL and IgG antibody negative Not recommended if CD4+ T cells <200/mL |
Herpes zoster virus |
Consider use of 1 dose in patients with CD4+ T cells >200-350/mL and VZV IgG antibody seropositive Not recommended if CD4+ T cells <200/mL |